Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilars are alternatives to existing patented and approved biologics that have similar medicinal properties compared to the original biologics. Biosimilars are slightly different in structure from the original biosimilars but must have similar safety and efficacy profiles compared to the original biosimilars.
The market for biosimilars is characterized by a large number of pharmaceutical giants and emerging enterprises all over the world. Europe region is expected to lead the global market owing to the presence of many major players in the region. The global Biosimilars market is expected to reach USD 44.56 Billion by year 2026, at a CAGR of 28.7%.
The global biosimilars market is driven by factors such as the global prevalence of target disease prevalence across the globe, the launch of biosimilars by various market players, and favorable investments scenario. However, risks to drug efficacy and stringent government regulations are expected to adversely affect market growth.
This report elaborates on the current development of the Biosimilars industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Amgen
Biocon
Hospira
Mylan
Merck KGaA
Teva Pharmaceutical
Celltrion
Roche Diagnostics
Sandoz International
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection
Tablets
Others
Application:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biosimilars Industry Overview
-
1.1.1 Biosimilars Market Scope and Market Segments
-
1.1.2 Biosimilars Industry Characteristics
-
1.1.3 Global and China Biosimilars Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biosimilars Production Value and Growth Rate (2017-2028)
-
1.2 Global Biosimilars Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection
-
1.2.2 Tablets
-
1.2.3 Others
-
1.3 Global Biosimilars Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Ankylosing Spondylitis
-
1.3.2 Tumor
-
1.3.3 Rheumatoid Arthrtis
-
1.3.4 Cardiovascular
-
1.4 Market Analysis by Region
-
1.4.1 North America Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biosimilars Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biosimilars Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biosimilars Industry Porter's Five Forces Model Analysis
-
2.2.3 Biosimilars Industry PEST Analysis
-
2.3 Biosimilars Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biosimilars Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biosimilars Industry
Chapter 3 Global and China Biosimilars Market, by Manufacturer
-
3.1 Global and China Biosimilars Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biosimilars Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biosimilars Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biosimilars Market Top 3 Players
Chapter 4 Global and China Biosimilars Market, by Type (2017-2028)
-
4.1 Biosimilars Market Trend, by Type
-
4.2 Global Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biosimilars Price Trend, by Type (2017-2028)
-
4.3 China Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biosimilars Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biosimilars Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biosimilars Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biosimilars Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biosimilars Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biosimilars Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biosimilars Market Analysis
-
7.1 North America Biosimilars Market, by Type
-
7.2 North America Biosimilars Market, by Application
-
7.3 North America Biosimilars Market Analysis and Forecast, by Country
-
7.3.1 United States Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biosimilars Market Analysis
-
8.1 Europe Biosimilars Market, by Type
-
8.2 Europe Biosimilars Market, by Application
-
8.3 Europe Biosimilars Market Analysis and Forecast, by Country
-
8.3.1 Germany Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biosimilars Market Analysis
-
9.1 APAC Biosimilars Market, by Type
-
9.2 APAC Biosimilars Market, by Application
-
9.3 APAC Biosimilars Market Analysis and Forecast, by Country
-
9.3.1 China Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biosimilars Market Analysis
-
10.1 Latin America, Middle East and Africa Biosimilars Market, by Type
-
10.2 Latin America, Middle East and Africa Biosimilars Market, by Application
-
10.3 Latin America, Middle East and Africa Biosimilars Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biosimilars Company Profiles
-
11.1 Amgen
-
11.1.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Amgen Biosimilars Product Profiles, Application and Specification
-
11.1.3 Amgen Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Biocon
-
11.2.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Biocon Biosimilars Product Profiles, Application and Specification
-
11.2.3 Biocon Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Hospira
-
11.3.1 Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Hospira Biosimilars Product Profiles, Application and Specification
-
11.3.3 Hospira Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Mylan
-
11.4.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Mylan Biosimilars Product Profiles, Application and Specification
-
11.4.3 Mylan Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Merck KGaA
-
11.5.1 Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Merck KGaA Biosimilars Product Profiles, Application and Specification
-
11.5.3 Merck KGaA Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Teva Pharmaceutical
-
11.6.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Teva Pharmaceutical Biosimilars Product Profiles, Application and Specification
-
11.6.3 Teva Pharmaceutical Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Celltrion
-
11.7.1 Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Celltrion Biosimilars Product Profiles, Application and Specification
-
11.7.3 Celltrion Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Roche Diagnostics
-
11.8.1 Roche Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Roche Diagnostics Biosimilars Product Profiles, Application and Specification
-
11.8.3 Roche Diagnostics Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Sandoz International
-
11.9.1 Sandoz International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Sandoz International Biosimilars Product Profiles, Application and Specification
-
11.9.3 Sandoz International Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biosimilars Industry Investment Prospect and Risk Assessment
-
12.1 Biosimilars Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biosimilars Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure China Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Tablets (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Tumor (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis (2017-2028)
-
Figure Global Biosimilars Market Size and Growth Rate of Cardiovascular (2017-2028)
-
Figure North America Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biosimilars Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biosimilars Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biosimilars Market Share, by Manufacturer in 2021
-
Figure Global and China Biosimilars Market Share, by Manufacturer in 2022
-
Table Global Biosimilars Sales Volume, by Type (2017-2028)
-
Table Global Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Global Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Global Biosimilars Sales Value, by Type (2017-2028)
-
Table Global Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure Global Biosimilars Price Trend, by Type (2017-2028)
-
Table China Biosimilars Sales Volume, by Type (2017-2028)
-
Table China Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure China Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table China Biosimilars Sales Value, by Type (2017-2028)
-
Table China Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure China Biosimilars Price Trend, by Type (2017-2028)
-
Table Global Biosimilars Sales Volume, by Application (2017-2028)
-
Table Global Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Global Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table Global Biosimilars Sales Value, by Application (2017-2028)
-
Table Global Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure Global Biosimilars Sales Value Share, by Application (2017-2028)
-
Table China Biosimilars Sales Volume, by Application (2017-2028)
-
Table China Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table China Biosimilars Sales Value, by Application (2017-2028)
-
Table China Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Table North America Biosimilars Sales Volume, by Type (2017-2028)
-
Table North America Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure North America Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table North America Biosimilars Sales Volume, by Application (2017-2028)
-
Table North America Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure North America Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure United States Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Europe Biosimilars Sales Volume, by Type (2017-2028)
-
Table Europe Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Europe Biosimilars Sales Volume, by Application (2017-2028)
-
Table Europe Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure UK Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure France Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure France Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table APAC Biosimilars Sales Volume, by Type (2017-2028)
-
Table APAC Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table APAC Biosimilars Sales Volume, by Application (2017-2028)
-
Table APAC Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure India Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure India Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilars Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilars Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Product Profiles, Application and Specification
-
Table Biocon Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hospira Product Profiles, Application and Specification
-
Table Hospira Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Product Profiles, Application and Specification
-
Table Mylan Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck KGaA Product Profiles, Application and Specification
-
Table Merck KGaA Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical Product Profiles, Application and Specification
-
Table Teva Pharmaceutical Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celltrion Product Profiles, Application and Specification
-
Table Celltrion Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Diagnostics Product Profiles, Application and Specification
-
Table Roche Diagnostics Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sandoz International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sandoz International Product Profiles, Application and Specification
-
Table Sandoz International Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
